What is it about?
A cohort of 4,069 patients with IgA nephropathy (IgAN) from Swedish biopsy registers was collected for this study. The diagnosis was validated through review of patient charts from 127 randomly selected patients. The positive predictive value (PPV) of a biopsy consistent with IgAN was 95%. Clinical characteristics of the cohort are in line with earlier studies.
Featured Image
Why is it important?
This is a validation study which may serve as a quality Control of a cohort that will be used for further epidemiological studies, examining association between IgA nephropathy and other disease and mortality.
Read the Original
This page is a summary of: Clinical validation of immunoglobulin A nephropathy diagnosis in Swedish biopsy registers, Clinical Epidemiology, January 2017, Dove Medical Press,
DOI: 10.2147/clep.s118730.
You can read the full text:
Contributors
The following have contributed to this page
